Preliminary research reveal conolidine may inhibit certain ion channels, decreasing neuronal excitability and limiting agony alerts. This mechanism is particularly related in neuropathic discomfort, the place irregular signaling will cause persistent discomfort. Additionally, conolidine appears to influence G protein-coupled receptor (GPCR) pathway